Vera Therapeutics (VERA) Competitors $20.39 -0.85 (-4.00%) Closing price 04:00 PM EasternExtended Trading$21.13 +0.74 (+3.65%) As of 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERA vs. TGTX, TLX, VRNA, LNTH, AXSM, GRFS, NUVL, ADMA, PCVX, and KRYSShould you be buying Vera Therapeutics stock or one of its competitors? The main competitors of Vera Therapeutics include TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Verona Pharma (VRNA), Lantheus (LNTH), Axsome Therapeutics (AXSM), Grifols (GRFS), Nuvalent (NUVL), ADMA Biologics (ADMA), Vaxcyte (PCVX), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry. Vera Therapeutics vs. TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Verona Pharma Lantheus Axsome Therapeutics Grifols Nuvalent ADMA Biologics Vaxcyte Krystal Biotech Vera Therapeutics (NASDAQ:VERA) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, community ranking, valuation, institutional ownership, media sentiment, profitability and dividends. Does the media refer more to VERA or TGTX? In the previous week, Vera Therapeutics had 4 more articles in the media than TG Therapeutics. MarketBeat recorded 15 mentions for Vera Therapeutics and 11 mentions for TG Therapeutics. TG Therapeutics' average media sentiment score of 1.25 beat Vera Therapeutics' score of 1.17 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vera Therapeutics 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TG Therapeutics 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, VERA or TGTX? TG Therapeutics has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVera TherapeuticsN/AN/A-$95.99M-$3.00-6.81TG Therapeutics$386.39M13.96$12.67M$0.24141.52 Which has more volatility and risk, VERA or TGTX? Vera Therapeutics has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 2.21, suggesting that its share price is 121% more volatile than the S&P 500. Do insiders and institutionals hold more shares of VERA or TGTX? 99.2% of Vera Therapeutics shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 16.3% of Vera Therapeutics shares are held by insiders. Comparatively, 10.6% of TG Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in VERA or TGTX? TG Therapeutics received 616 more outperform votes than Vera Therapeutics when rated by MarketBeat users. Likewise, 76.27% of users gave TG Therapeutics an outperform vote while only 66.15% of users gave Vera Therapeutics an outperform vote. CompanyUnderperformOutperformVera TherapeuticsOutperform Votes4366.15% Underperform Votes2233.85% TG TherapeuticsOutperform Votes65976.27% Underperform Votes20523.73% Is VERA or TGTX more profitable? Vera Therapeutics has a net margin of 0.00% compared to TG Therapeutics' net margin of -5.42%. TG Therapeutics' return on equity of -8.32% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vera TherapeuticsN/A -50.13% -39.50% TG Therapeutics -5.42%-8.32%-3.40% Do analysts prefer VERA or TGTX? Vera Therapeutics currently has a consensus target price of $63.33, indicating a potential upside of 210.00%. TG Therapeutics has a consensus target price of $40.80, indicating a potential upside of 20.12%. Given Vera Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Vera Therapeutics is more favorable than TG Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.10TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 SummaryVera Therapeutics and TG Therapeutics tied by winning 9 of the 18 factors compared between the two stocks. Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERA vs. The Competition Export to ExcelMetricVera TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.30B$6.55B$5.40B$8.53BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-7.839.1626.7419.97Price / SalesN/A258.53394.93122.22Price / CashN/A65.8538.2534.62Price / Book10.536.546.874.59Net Income-$95.99M$143.98M$3.23B$248.18M7 Day Performance-3.59%4.65%5.01%2.15%1 Month Performance-3.22%9.18%12.82%16.14%1 Year Performance-48.62%-1.33%17.63%8.06% Vera Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERAVera Therapeutics3.3651 of 5 stars$20.39-4.0%$63.33+210.6%-48.2%$1.30BN/A-7.8140Positive NewsTGTXTG Therapeutics3.8254 of 5 stars$34.99+4.0%$40.80+16.6%+115.2%$5.56B$386.39M-349.87290Positive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.25-5.4%$22.00+35.4%N/A$5.49B$783.21M0.00N/AGap DownVRNAVerona Pharma2.6775 of 5 stars$67.53+6.6%$81.50+20.7%+484.7%$5.48B$118.54M-35.1730Positive NewsLNTHLantheus4.458 of 5 stars$79.52-2.7%$132.67+66.8%-7.3%$5.45B$1.54B13.23700Positive NewsHigh Trading VolumeAXSMAxsome Therapeutics4.7267 of 5 stars$110.16+2.2%$172.14+56.3%+39.7%$5.42B$432.16M-18.39380Positive NewsInsider TradeGRFSGrifols3.2195 of 5 stars$7.73+8.9%N/A+4.7%$5.31B$7.21B6.6126,300Positive NewsNUVLNuvalent2.6421 of 5 stars$73.63+5.4%$115.50+56.9%+7.0%$5.27BN/A-21.2240News CoveragePositive NewsADMAADMA Biologics3.1796 of 5 stars$20.45+2.4%$24.25+18.6%+117.2%$4.86B$459.38M73.04530News CoveragePositive NewsGap DownPCVXVaxcyte3.0977 of 5 stars$31.59+1.4%$136.50+332.1%-51.8%$4.08BN/A-6.87160News CoveragePositive NewsEarnings ReportGap UpKRYSKrystal Biotech4.8578 of 5 stars$139.43+5.5%$218.63+56.8%-20.0%$4.03B$333.45M46.63210 Related Companies and Tools Related Companies TG Therapeutics Competitors Telix Pharmaceuticals Limited American Depositary Shares Competitors Verona Pharma Competitors Lantheus Competitors Axsome Therapeutics Competitors Grifols Competitors Nuvalent Competitors ADMA Biologics Competitors Vaxcyte Competitors Krystal Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
